Archive
Year
Volume(Issue)
Issues
Journal Article
Download
فارسی Version
Triple combination of interferon beta-1b, lopinavir–, ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
LANCET
Year:
Volume:
Issue:
Pages:
Citations:
Views:
Downloads:
more
View 28
Sharpening the global focus on ethnicity and race in the time of COVID-19
View 25
Prevention and control of non-communicable diseases in the COVID-19 response
View 45
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: An open-label, randomised, phase 2 trial
View 65
Use of renin-angiotensinaldosterone system inhibitors and risk of covid-19 requiring admission to hospital: A case-population study
View 19